Transgender men, transmasculine, and nonbinary people experience barriers to accessing health care, especially services that are traditionally gendered, such as gynecological care. In addition, very little is understood how testosterone impacts several aspects of pelvic and sexual health, including genital atrophy, genital infections (like bacterial vaginosis and yeast infection), endometriosis, and polycystic ovarian syndrome (PCOS).

This study is specifically examining the experiences of transgender and nonbinary people who are currently using testosterone gender-affirming hormone therapy have in accessing gynecological care. We also hope to understand some of the barriers and facilitators of accessing care and gaps in provider knowledge and awareness. We hope that the findings from this study will help enhance medical care, resources, services, and support for transgender and nonbinary people.

We are looking for transgender men, transmasculine, and nonbinary people who are adults (age 18 and older) and currently use testosterone gender-affirming hormone therapy to participate in one-one-one interviews. Interviews will be held remotely over the Internet using the videoconferencing software Zoom and will last between 60-90 minutes. Your identity will be kept confidential throughout the research process.

This questionnaire will help determine eligibility for participating in interviews.

After completing this short screening survey, you may be contacted to participate in a community listening session hosted by PRIDEnet. If you are eligible to participate in the community listening session and attend the session, then you will be provided an Amazon.com Gift Card in the amount of US$50.00 within 15 business days of completion of the session.

Learn more